Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Journal of Reproductive Immunology|March 16, 2010
Cord blood as a source of non-senescent lymphocytes for tumor immunotherapyAnastasios E Germenis, Vaios KaranikasClinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2016
The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint InhibitionPriti S Hegde, Vaios Karanikas, Stefan EversImmunology Letters|July 24, 2007
Tumor immune escape mediated by indoleamine 2,3-dioxygenaseMaria Zamanakou, Anastasios E Germenis, Vaios KaranikasCancer Letters|April 22, 2009
Anti-survivin antibody responses in lung cancerVaios Karanikas, Sanaa Khalil, Theodora Kerenidi, et al.Immunology and Cell Biology|February 10, 2010
Naturally occurring tumor-specific CD8+ T-cell precursors in individuals with and without cancerVaios Karanikas, Maria Zamanakou, Faye Soukou, et al.European Journal of Immunology|January 31, 2003
Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigensLydie Trautmann, Nathalie Labarrière, Francine Jotereau, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2021
Biomarker Technologies to Support Early Clinical Immuno-oncology Development: Advances and InterpretationMichael A Cannarile, Bruno Gomes, Marta Canamero, et al.Clinical Immunology (Orlando, Fla.)|September 16, 2008
Baseline levels of CD8+ T cells against survivin and survivin-2B in the blood of lung cancer patients and cancer-free individualsVaios Karanikas, Faye Soukou, Fani Kalala, et al.Cancer Biology & Therapy|August 19, 2007
Indoleamine 2,3-dioxygenase (IDO) expression in lung cancerVaios Karanikas, Maria Zamanakou, Theodora Kerenidi, et al.Clinical Immunology (Orlando, Fla.)|February 24, 2011
Survivin isoform expression patterns in CML patients correlate with resistance to imatinib and progression, but do not trigger cytolytic responsesMatthaios Speletas, Nikoletta Argentou, Vaios Karanikas, et al.Pageof 4